Author:
Mori Hiroshi,Nakayama Ken-ichi,Maeda Daishirou,Nagai Hiroichi,Koda Akihide,Kita Jun-ichiru,Kaku Yoshio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference15 articles.
1. Akazawa S, Kumai R, Yoshida K, Ayusawa D, Shimizu K, Seno T (1986) The cytotoxicity of 5-fluorouracil is due to its incorporation into RNA not its inhibition of thymidylate synthetase as evidenced by the use of a mouse cell mutant deficient in thymidylate synthetase. Jpn J Cancer Res 77: 620
2. Heidelberger C, Dushinsky R (1957) Fluorinated pyrimidine. A new class of tumor inhibitory compounds. Nature 179: 663
3. Kanamura R, Kakuta H, Sato T, Ishioka C, Wakui A (1986) The inhibitory effect of 5-fluorouracil on the metabolism of preribosomal RNA in L1210 cells in vitro. Cancer Chemother Pharmacol 17: 43
4. Koda A, Mori H, Nagai H (1978) Effect of ?-mercaptopropionylglycine (?-MPG) and sodium dipropylacetate (DPA) on antibody formation (I) (in Japanese with English abstract). Nippon Yakurigaku Zasshi 74: 451
5. Kufe DW, Egan EM (1981) Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid. Biochem Pharmacol 30: 129